NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.30 Cr |
What is the latest Cash Flow from Financing Activities ratio of NGL FINECHEM ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-1.08 Cr |
Mar2023 | ₹-1.08 Cr |
Mar2022 | ₹-1.08 Cr |
Mar2021 | ₹-1.08 Cr |
Mar2020 | ₹-1.30 Cr |
How is Cash Flow from Financing Activities of NGL FINECHEM Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1.08 Cr | Negative | |
Mar2023 | ₹-1.08 Cr | Negative | |
Mar2022 | ₹-1.08 Cr | Negative | |
Mar2021 | ₹-1.08 Cr | Negative | |
Mar2020 | ₹-1.30 Cr | - |
Compare Cash Flow from Financing Activities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹699.3 Cr | 1.6% | 1.9% | -53.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -4.9% | 2.1% | 15.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,310.0 Cr | -2.2% | 9.3% | 50.5% | Stock Analytics | |
CIPLA | ₹119,410.0 Cr | -4.2% | 4.5% | 4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -4.4% | -4.5% | 17.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,496.4 Cr | -1.4% | 4.2% | -8.8% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 1.6% |
1.9% |
-53.4% |
SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses